141 related articles for article (PubMed ID: 33905805)
1. The chorioallantoic membrane as a bio-barrier model for the evaluation of nanoscale drug delivery systems for tumour therapy.
Preis E; Schulze J; Gutberlet B; Pinnapireddy SR; Jedelská J; Bakowsky U
Adv Drug Deliv Rev; 2021 Jul; 174():317-336. PubMed ID: 33905805
[TBL] [Abstract][Full Text] [Related]
2. Optimising the chick chorioallantoic membrane xenograft model of neuroblastoma for drug delivery.
Swadi R; Mather G; Pizer BL; Losty PD; See V; Moss D
BMC Cancer; 2018 Jan; 18(1):28. PubMed ID: 29301505
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticles characterization using the CAM assay.
Grace Intasa-Ard S; Birault A
Enzymes; 2019; 46():129-160. PubMed ID: 31727274
[TBL] [Abstract][Full Text] [Related]
4. A chorioallantoic membrane model for the determination of anti-angiogenic effects of imatinib.
Özcetin A; Aigner A; Bakowsky U
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):711-5. PubMed ID: 23891770
[TBL] [Abstract][Full Text] [Related]
5. The chick embryo and its chorioallantoic membrane (CAM) for the in vivo evaluation of drug delivery systems.
Vargas A; Zeisser-Labouèbe M; Lange N; Gurny R; Delie F
Adv Drug Deliv Rev; 2007 Sep; 59(11):1162-76. PubMed ID: 17870202
[TBL] [Abstract][Full Text] [Related]
6. Chick embryo chorioallantoic membrane as a suitable in vivo model to evaluate drug delivery systems for cancer treatment: A review.
Victorelli FD; Cardoso VMO; Ferreira NN; Calixto GMF; Fontana CR; Baltazar F; Gremião MPD; Chorilli M
Eur J Pharm Biopharm; 2020 Aug; 153():273-284. PubMed ID: 32580050
[TBL] [Abstract][Full Text] [Related]
7. The In Ovo Chick Chorioallantoic Membrane (CAM) Assay as an Efficient Xenograft Model of Hepatocellular Carcinoma.
Li M; Pathak RR; Lopez-Rivera E; Friedman SL; Aguirre-Ghiso JA; Sikora AG
J Vis Exp; 2015 Oct; (104):. PubMed ID: 26484588
[TBL] [Abstract][Full Text] [Related]
8. Chick ex ovo culture and ex ovo CAM assay: how it really works.
Dohle DS; Pasa SD; Gustmann S; Laub M; Wissler JH; Jennissen HP; Dünker N
J Vis Exp; 2009 Nov; (33):. PubMed ID: 19949373
[TBL] [Abstract][Full Text] [Related]
9.
Moreno-Jiménez I; Kanczler JM; Hulsart-Billstrom G; Inglis S; Oreffo ROC
Tissue Eng Part C Methods; 2017 Dec; 23(12):938-952. PubMed ID: 28877648
[TBL] [Abstract][Full Text] [Related]
10. The Preparation of Chicken Ex Ovo Embryos and Chorioallantoic Membrane Vessels as In Vivo Model for Contrast-Enhanced Ultrasound Imaging and Microbubble-Mediated Drug Delivery Studies.
Meijlink B; Skachkov I; van der Steen AFW; de Jong N; Kooiman K
J Vis Exp; 2021 Feb; (168):. PubMed ID: 33645558
[TBL] [Abstract][Full Text] [Related]
11. The CAM Assay as an Alternative In Vivo Model for Drug Testing.
Schneider-Stock R; Ribatti D
Handb Exp Pharmacol; 2021; 265():303-323. PubMed ID: 32776283
[TBL] [Abstract][Full Text] [Related]
12. Optimization of the chicken chorioallantoic membrane assay as reliable in vivo model for the analysis of osteosarcoma.
Kunz P; Schenker A; Sähr H; Lehner B; Fellenberg J
PLoS One; 2019; 14(4):e0215312. PubMed ID: 30986223
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticles carrying fingolimod and methotrexate enables targeted induction of apoptosis and immobilization of invasive thyroid cancer.
Niemelä E; Desai D; Niemi R; Doroszko M; Özliseli E; Kemppainen K; Rahman NA; Sahlgren C; Törnquist K; Eriksson JE; Rosenholm JM
Eur J Pharm Biopharm; 2020 Mar; 148():1-9. PubMed ID: 31917332
[TBL] [Abstract][Full Text] [Related]
14. The Chicken Egg Chorioallantoic Membrane (CAM) Model as an In Vivo Method for the Investigation of the Invasion and Metastasis Cascade of Malignant Tumor Cells.
Leupold JH; Patil N; Allgayer H
Methods Mol Biol; 2021; 2294():17-26. PubMed ID: 33742391
[TBL] [Abstract][Full Text] [Related]
15. Tetraiodothyroacetic acid and tetraiodothyroacetic acid nanoparticle effectively inhibit the growth of human follicular thyroid cell carcinoma.
Yalcin M; Bharali DJ; Dyskin E; Dier E; Lansing L; Mousa SS; Davis FB; Davis PJ; Mousa SA
Thyroid; 2010 Mar; 20(3):281-6. PubMed ID: 20187783
[TBL] [Abstract][Full Text] [Related]
16. Depletion of Embryonic Macrophages Leads to a Reduction in Angiogenesis in the Ex Ovo Chick Chorioallantoic Membrane Assay.
Tay H; Du Cheyne C; Demeyere K; De Craene J; De Bels L; Meyer E; Zijlstra A; Spiegelaere W
Cells; 2020 Dec; 10(1):. PubMed ID: 33375076
[TBL] [Abstract][Full Text] [Related]
17. Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2.
Lai L; Liu J; Zhai D; Lin Q; He L; Dong Y; Zhang J; Lu B; Chen Y; Yi Z; Liu M
Br J Pharmacol; 2012 Feb; 165(4b):1084-96. PubMed ID: 21658027
[TBL] [Abstract][Full Text] [Related]
18. Chick chorioallantoic membrane as an in situ biological membrane for pharmaceutical formulation development: a review.
Saw CL; Heng PW; Liew CV
Drug Dev Ind Pharm; 2008 Nov; 34(11):1168-77. PubMed ID: 18663656
[TBL] [Abstract][Full Text] [Related]
19. Regulatory Acceptance of Alternative Methods in the Development and Approval of Pharmaceuticals.
Beken S; Kasper P; van der Laan JW
Adv Exp Med Biol; 2016; 856():33-64. PubMed ID: 27671719
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic-induced vascular damage of the chick chorioallantoic membrane model using perylenequinones.
Chin W; Lau W; Lay SL; Wei KK; Olivo M
Int J Oncol; 2004 Oct; 25(4):887-91. PubMed ID: 15375536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
